欢迎来到《四川大学学报(医学版)》
刘小锦, 李文龙, 彭友悦等. 四川省绵阳市1~12岁儿童乙肝表面抗原和乙肝表面抗体的分布现况[J]. 四川大学学报(医学版), 2018, 49(2): 304-308.
引用本文: 刘小锦, 李文龙, 彭友悦等. 四川省绵阳市1~12岁儿童乙肝表面抗原和乙肝表面抗体的分布现况[J]. 四川大学学报(医学版), 2018, 49(2): 304-308.
LIU Xiao-jin, LI Wen-long, PENG You-yue. et al. Prevalence of Hepatitis B Surface Antigens and Hepatitis B Surface Antibodies in 1-12 Years-old Children in Mianyang, Sichuan[J]. Journal of Sichuan University (Medical Sciences), 2018, 49(2): 304-308.
Citation: LIU Xiao-jin, LI Wen-long, PENG You-yue. et al. Prevalence of Hepatitis B Surface Antigens and Hepatitis B Surface Antibodies in 1-12 Years-old Children in Mianyang, Sichuan[J]. Journal of Sichuan University (Medical Sciences), 2018, 49(2): 304-308.

四川省绵阳市1~12岁儿童乙肝表面抗原和乙肝表面抗体的分布现况

Prevalence of Hepatitis B Surface Antigens and Hepatitis B Surface Antibodies in 1-12 Years-old Children in Mianyang, Sichuan

  • 摘要: 目的了解四川省绵阳市1~12岁儿童乙肝表面抗原(HBsAg)和乙肝表面抗体(抗-HBs)的分布现况,为制定和完善儿童乙肝疫苗免疫规划策略提供依据。方法2015年1~12月,采用多阶段分层随机整群抽样方法,抽取绵阳市乙肝计划免疫实施后出生的1~12岁儿童72 623名,对其进行个人信息采集和血标本采集,用ELISA法检测血清HBsAg和抗-HBs,对HBsAg阳性者进行复检。结果绵阳市1~12岁儿童的HBsAg阳性率为0.24%,抗-HBs阳性率为64.50%,HBsAg与抗-HBs双阴性率为35.26%,根据2010年全国第六次人口普查标准化率分别为0.24%、64.05%和35.71%。1~12岁各年龄组儿童的HBsAg阳性率为0%~0.65%,随着年龄增大呈升高趋势(P<0.001),农村儿童HBsAg阳性率(0.32%)高于城市儿童(0.16%,P<0.001),有乙肝家族史儿童HBsAg阳性率(1.53%)高于无家族史儿童(0.22%,P<0.001);1~12岁各年龄组儿童的抗-HBs阳性率为47.85%~71.43%,随着年龄增大呈降低趋势(P<0.001),农村儿童抗-HBs阳性率(62.06%)低于城市儿童(66.81%,P<0.001);1~12岁各年龄组儿童HBsAg与抗-HBs双阴性率为28.57%~51.98%,随着年龄增大呈升高趋势(P<0.001),农村儿童HBsAg与抗-HBs双阴性率(37.62%)高于城市儿童(33.03%,P<0.001),无乙肝免疫史儿童HBsAg与抗-HBs双阴性率为35.37%。结论绵阳市乙肝计划免疫工作取得显著成效,但不同特征儿童抗-HBs阳性率存在差异,乙型肝炎病毒易感儿童仍占一定比例,应重视新生儿乙肝疫苗的接种,积极开展儿童抗-HBs水平监测,对缺乏抗体保护的儿童实施加强免疫。

     

    Abstract: Objective To determine the prevalence of hepatitis B surface antigens (HBsAg) and hepatitis B surface antibodies (anti-HBs) in 1-12 years-old children in Mianyang city, Sichuan Province. Methods Children born after the implementation of Hepatitis B immunization policy were selected using a stratified random cluster sampling strategy from January to December 2015. A total of 72 623 eligible children participated in the study, which included a questionnaire survey and blood tests (0.3 mL vein blood) for HBsAg and anti-HBs with ELISA method. Repeated tests were performed on the blood samples with a HBsAg positive result. Results About 0.24% of the children were HBsAg positive; 64.50% were anti-HBs positive; 35.26% were both HBsAg and anti-HBs negative. The standardized rates based on the 2010 population census were: 0.24% HBsAg positive, 64.05% anti-HBs positive, and 35.71% both HBsAg and anti-HBs negative. HBsAg positive rates increased with age, ranging from 0% to 0.65% (P<0.001). Rural children had a higher HBsAg positive rate (0.32%) than their urban counterparts (0.16%, P<0.001). Those with a family history of Hepatitis B had a higher HBsAg positive rate (1.53%) than those without a family history (0.22%, P<0.001). Anti-HBs positive rates decreased withage, ranging from 47.85% to 71.43% (P<0.001). Rural children had a lower anti-HBs positive rate (62.06%)than their urban counterparts (66.81%, P<0.001). The prevalence of both HBsAg and anti-HBs negative cases increased with age, ranging from 28.57% to 51.98% (P<0.001). Rural children had a higher rate of both HBsAg and anti-HBs negative (37.62%) than their urban counterparts (33.03%, P<0.001). About 35.37% of the children who had negative HBsAg and anti-HBs had not received Hepatitis B immunization. Conclusions Hepatitis B vaccinations are highly effective in Mianyang. However, there are disparities in anti-HBs positive rates between the children with different characteristics. A certain proportion of children are still susceptible to hepatitis B infection. It is necessary to attach importance to neonatal hepatitis B vaccination, surveillance on anti-HBs, and strengthened immunization for the children who are lack of antibody protection.

     

© 2018 《四川大学学报(医学版)》编辑部 版权所有 cc

开放获取 本文遵循知识共享署名—非商业性使用4.0国际许可协议(CC BY-NC 4.0),允许第三方对本刊发表的论文自由共享(即在任何媒介以任何形式复制、发行原文)、演绎(即修改、转换或以原文为基础进行创作),必须给出适当的署名,提供指向本文许可协议的链接,同时标明是否对原文作了修改;不得将本文用于商业目的。CC BY-NC 4.0许可协议详情请访问 https://creativecommons.org/licenses/by-nc/4.0

/

返回文章
返回